Targretin
Targretin (bexarotene) gel 1% Rx only
Approved
Approval ID
d35b4697-3f3b-4aa1-b5d9-153993e83811
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 3, 2020
Manufacturers
FDA
Bausch Health US, LLC
DUNS: 831922468
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
bexarotene
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code0187-5525
Application NumberNDA021056
Product Classification
M
Marketing Category
C73594
G
Generic Name
bexarotene
Product Specifications
Route of AdministrationTOPICAL
Effective DateFebruary 3, 2020
FDA Product Classification
INGREDIENTS (5)
BEXAROTENEActive
Quantity: 1 g in 100 g
Code: A61RXM4375
Classification: ACTIB
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
ALCOHOLInactive
Code: 3K9958V90M
Classification: IACT
HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive
Code: 9XZ8H6N6OH
Classification: IACT
BUTYLATED HYDROXYTOLUENEInactive
Code: 1P9D0Z171K
Classification: IACT